Literature DB >> 25372924

Psychological assessment before heart transplantation: more hope to candidates in Brazil?

Reinaldo B Bestetti1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25372924      PMCID: PMC4412339          DOI: 10.5935/1678-9741.20140098

Source DB:  PubMed          Journal:  Rev Bras Cir Cardiovasc


× No keyword cloud information.
To the Editor, I have read with great interest the paper by Cunha et al.[ which presents the results of a psychological assessment of candidates to heart transplantation. They evaluated 60 candidates to heart transplantation from 2004 to 2012, 73% with a stable partner. By using the SF-36 Health survey, the Beck Depression Inventory, and a personal interview, they observed that indices of quality of life were lower in women in comparison to men, specifically on functional capacity, vitality, emotional aspects, and general mental health. They concluded that patients with psychosocial vulnerability should receive psychological care. I agree. Psychological evaluation is paramount in candidates to heart transplantation, inasmuch as pretransplant factors may be associated with adverse outcome in post-transplant patients. In fact, lower received social support, higher education, and lower conscientiousness detected on the waiting list are independent predictors of post-transplant adherence with medication, which is associated with acute rejection[. Furthermore, the presence of psychiatric problems in the pretransplant period continues following heart transplantation[, including substance abuse[. Moreover, previous suicide attempt, alcohol rehabilitation, and depression are associated with decreased survival[. Therefore, unfavorable psychological profile, characterized by previous suicide attempt as well as substance abuse, may preclude candidates to undergo heart transplantation[. It is, therefore, reassuring to see that patients reported by Cunha et al.[ do not fit, in general, in the unfavorable psychological profile, as outlined earlier, to the point to be excluded from the waiting list of heart transplantation. In addition, it is of utmost importance to perceive that the majority of them had a stable partner who will act as caregiver following the procedure. Thus, I believe that, by offering proper psychological support to vulnerable patients, mainly to women, we can perform heart transplantation successfully in patients with minor psychological disorders, as we did to patients with low socioeconomic profile[.
  5 in total

1.  Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival.

Authors:  Jason E Owen; Curley L Bonds; David K Wellisch
Journal:  Psychosomatics       Date:  2006 May-Jun       Impact factor: 2.386

2.  Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening.

Authors:  Fabienne Dobbels; Johan Vanhaecke; Lieven Dupont; Frederik Nevens; Geert Verleden; Jacques Pirenne; Sabina De Geest
Journal:  Transplantation       Date:  2009-05-27       Impact factor: 4.939

3.  Psychological assessment of patients undergoing cardiac transplant in a teaching hospital (2004 to 2012).

Authors:  Sara dos Santos Cunha; Maria Cristina de Oliveira Santos Miyazaki; Daniel Fernando Villafanha; Randolfo dos Santos Junior; Neide Aparecida Micelli Domingos
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jul-Sep

4.  Impact of socioeconomic status on outcome of a Brazilian heart transplant recipients cohort.

Authors:  Andrelisa V Parra; Vanessa Rodrigues; Sônia Cancella; José A Cordeiro; Reinaldo B Bestetti
Journal:  Int J Cardiol       Date:  2007-04-02       Impact factor: 4.164

5.  Study of the relative incidences of psychosocial factors before and after heart transplantation and the influence of posttransplantation psychosocial factors on heart transplantation outcome.

Authors:  W Paris; J Muchmore; A Pribil; N Zuhdi; D K Cooper
Journal:  J Heart Lung Transplant       Date:  1994 May-Jun       Impact factor: 10.247

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.